Does the early intensification of intrathecal therapy improve outcomes in pediatric acute lymphoblastic leukemia patients with CNS2/TLP+ status at diagnosis?

about

Does the early intensification of intrathecal therapy improve outcomes in pediatric acute lymphoblastic leukemia patients with CNS2/TLP+ status at diagnosis?

Item

http://www.wikidata.org/entity/Q41717778

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Does the early intensification ...... CNS2/TLP+ status at diagnosis?

@en

type

Item

label

Does the early intensification ...... CNS2/TLP+ status at diagnosis?

@en

prefLabel

Does the early intensification ...... CNS2/TLP+ status at diagnosis?

@en

P1476

Does the early intensification ...... CNS2/TLP+ status at diagnosis?

@en

P2093

Khalid Abdalla

http://www.w3.org/2001/XMLSchema#string

Mohammed B Abrar

http://www.w3.org/2001/XMLSchema#string

Naglla Elimam

http://www.w3.org/2001/XMLSchema#string

Sami Felimban

http://www.w3.org/2001/XMLSchema#string

Taha M Khattab

http://www.w3.org/2001/XMLSchema#string

Wasil Jastaniah

http://www.w3.org/2001/XMLSchema#string

P2860

Treating childhood acute lymphoblastic leukemia without cranial irradiation

Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia

Glucocorticoid use in acute lymphoblastic leukaemia

Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic l

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

Current management and challenges of malignant disease in the CNS in paediatric leukaemia.

Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).

Delay of the diagnostic lumbar puncture and intrathecal chemotherapy in children with acute lymphoblastic leukemia who undergo routine corticosteroid testing: Tokyo Children's Cancer Study Group study L89-12.

Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital.

P304

561-566

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1179/1607845415Y.0000000020

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26010408

http://www.w3.org/2001/XMLSchema#string